Loading...
Clinical application prospect of umbilical cord-derived mesenchymal stem cells on clearance of advanced glycation end products through autophagy on diabetic wound
Han, Yanfu Sun, Tianjun Tao, Ran Han, Yanqing Liu, Jing
Han, Yanfu
Sun, Tianjun
Tao, Ran
Han, Yanqing
Liu, Jing
An error occurred retrieving the object's statistics
Citations
Altmetric:
Genre
Journal Article
Review
Review
Date
2017-03-24
Advisor
Committee member
Group
Department
Permanent link to this record
Collections
Research Projects
Organizational Units
Journal Issue
DOI
10.1186/s40001-017-0253-1
Abstract
Nowadays, wound healing delay due to diabetes is considered to be closely related to the accumulation of advanced glycation end products (AGEs). Although mesenchymal stem cells (MSCs) exhibit positive effects on diabetic wound healing, related mechanisms are still not fully elucidated. It has been reported that MSCs can improve the activity of autophagy in injured tissues, thereby playing an important role in wound healing. The autophagy induced by MSCs may be beneficial to diabetic wound healing via removing AGEs, which provide new ideas for clinical treatment of diabetic wounds with the potential of broad application prospects. In this study, the current research situation and application prospect of umbilical cord-derived MSCs on the clearance of AGEs in diabetic wound were reviewed.
Description
Citation
Citation to related work
Springer Science and Business Media LLC
Has part
EUROPEAN JOURNAL OF MEDICAL RESEARCH
ADA compliance
For Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu